Bill Text: NJ A4252 | 2020-2021 | Regular Session | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Requires availability of certain laboratory testing for coronavirus disease 2019.

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Engrossed - Dead) 2020-08-03 - Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [A4252 Detail]

Download: New_Jersey-2020-A4252-Introduced.html

---

ASSEMBLY, No. 4252

STATE OF NEW JERSEY

219th LEGISLATURE

 

INTRODUCED JUNE 15, 2020

 

 

Sponsored by:

Assemblyman  HERB CONAWAY, JR.

District 7 (Burlington)

 

 

 

 

SYNOPSIS

     Requires availability of certain laboratory testing for coronavirus disease 2019.

 

CURRENT VERSION OF TEXT

     As introduced.

  

An Act concerning coronavirus disease 2019 laboratory testing.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    a.  As used in this section:

     "Clinical laboratory" means a laboratory licensed by the Department of Health, pursuant to the "New Jersey Clinical Laboratory Improvement Act," P.L.1975, c.166 (C.45:9-42.26 et seq.).

     "Health care professional" means a person licensed to practice a health care profession pursuant to Title 45 of the Revised Statutes.

     b.    Subject to the availability of coronavirus disease 2019 tests, a clinical laboratory shall offer in-person diagnostic testing and in-person serologic testing for the coronavirus disease 2019 within the patient care sites of the clinical laboratory to patients who have been authorized by a health care professional to receive a test for the coronavirus disease 2019.  Such testing shall include nasopharyngeal or anterior nasal and saliva testing.

 

     2.    This act shall take effect immediately and shall expire upon the end of both the state of emergency and the public health emergency declared in response to the coronavirus disease 2019.

 

 

STATEMENT

 

     This bill requires the availability of certain laboratory testing for coronavirus disease 2019.

     The bill provides that, subject to the availability of coronavirus disease 2019 tests, a clinical laboratory is to offer in-person diagnostic testing and in-person serologic testing for the coronavirus disease 2019 within the patient care sites of the clinical laboratory to patients who have been authorized by a health care professional to receive a test for the coronavirus disease 2019.  Such testing is to include nasopharyngeal or anterior nasal and saliva testing.